Actinogen Medical Ltd

OTCPK:ATGGF (Australia)  
$ 0.02 +0.005 (+33.33%) 11:08 PM EST
At Loss
P/B:
3.57
Market Cap:
$ 46.94M
Enterprise V:
$ 41.24M
Volume:
-
Avg Vol (2M):
810.10K
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
810.10K

Business Description

Description
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 29.63
Equity-to-Asset 0.92
Debt-to-Equity 0.02
Debt-to-EBITDA -0.03
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 100
9-Day RSI 100
14-Day RSI 100

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.91
Quick Ratio 13.91
Cash Ratio 6.96

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.2
Shareholder Yield % -22.93

Profitability Rank

Name Current Vs Industry Vs History
ROE % -86.81
ROA % -77.21
ROIC % -379.39
ROC (Joel Greenblatt) % -7599.22
ROCE % -86.15

Financials

ATGGF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ATGGF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Actinogen Medical Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.004
Beta -2.01
Volatility % 33.33
14-Day RSI 100
14-Day ATR ($) 0.000095
20-Day SMA ($) 0.01975
12-1 Month Momentum % 0
52-Week Range ($) 0.015 - 0.02
Shares Outstanding (Mil) 3,132.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Actinogen Medical Ltd Filings

Filing Date Document Date Form
No Filing Data

Actinogen Medical Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Actinogen Medical Ltd Frequently Asked Questions

What is Actinogen Medical Ltd(ATGGF)'s stock price today?
The current price of ATGGF is $0.02. The 52 week high of ATGGF is $0.02 and 52 week low is $0.02.
When is next earnings date of Actinogen Medical Ltd(ATGGF)?
The next earnings date of Actinogen Medical Ltd(ATGGF) is .
Does Actinogen Medical Ltd(ATGGF) pay dividends? If so, how much?
Actinogen Medical Ltd(ATGGF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1